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Abstract: Cholecystokinin (CCK) acting through its G protein-coupled receptor is now known to activate a variety of
intracellular signaling mechanisms and thereby regulate a complex array of cellular functions in pancreatic acinar cells.
The best studied mechanism is the coupling through heterotrimeric G proteins of the Gq family to activate a phospholipase
C leading to an increase in inositol trisphosphate and release of intracellular Ca2π. This pathway along with protein
kinase C activation in response to the increase in diacylglycerol stimulates the secretion of digestive enzymes by the process
of exocytosis. CCK also activates signaling pathways in acini more related to other processes. The three mitogen activated
protein kinase cascades leading to ERKs, JNKs and p38 MAPK are all activated by CCK. CCK activates the ERK
cascade by PKC activation of Raf which in turn activates MEK and ERKs. JNKs are activated by a distinct mechanism
whish requires higher concentrations of CCK. Both ERKs and JNKs are presumed to regulate gene expression. CCK
activation of p38 MAPK also plays a role in regulating the actin cytoskeleton through phosphorylation of the small heat
shock protein HSP27. The PI3K-PKB-mTOR pathway is activated by CCK and plays a major role in regulating protein
synthesis at the translational level. This includes both activation of p70 S6K leading to phosphorylation of ribosomal
protein S6 and the phosphorylation of the binding protein for initiation factor 4E leading to formation of the mRNA
cap binding complex. Other signaling pathways activated by CCK receptors include NF-kB and a variety of tyrosine
kinases. Further work is needed to understand how CCK receptors activate most of the above pathways and to better
understand the biological events regulated by these diverse signaling pathways.
One of the most well studied target cells used to study re-
ceptors and signaling mechanism for cholecystokinin
(CCK) is the rodent pancreatic acinar cell. These cells pos-
sess relatively large numbers of CCKA receptors and a
readily measured biologic endpoint, the secretion of diges-
tive enzymes such as amylase. The pancreas can be digested
with collagenase to yield the functional unit, the isolated
acinus (Williams et al. 1978), or with further digestion, iso-
lated acinar cells. Isolated rat and mouse acini are very sen-
sitive to CCK and have been used to study ligand-receptor
interaction, measurement of classical second messengers,
activation of protein kinases and various biological effects
including secretion, protein synthesis and membrane trans-
port (Williams & Blevins 1993). They can also be used as a
sensitive bioassay for plasma CCK (Liddle et al. 1984).
Signaling mechanisms regulating enzyme secretion
Most of the early work on isolated pancreatic cells, acini
and lobules focused on secretion of digestive enzymes and
rapidly identified an increase in intracellular Ca2π as the
major controller by which CCK and the neurotransmitter,
acetylcholine activated enzyme secretion (Yule & Williams
1994). Acinar cells were instrumental in identifying the im-
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portance of intracellular Ca2π release and later the identifi-
cation of inositol trisphosphate (IP3) as the mediator of
Ca2π release. This early work led to a model which has been
continued to be filled in whereby the liganded CCK recep-
tor activates heterotrimeric G proteins of the Gq family,
especially Gq and G11. The G protein subunits then dis-
sociate and the a subunit activates a phospholipase C-b
which cleaves phosphatidylinositol 4,5-bisphosphate to
form IP3 and diacylglycerol (Matozaki & Williams 1989).
IP3 binds to an intracellular receptor (the IP3R) which
functions as a ligand gated ion channel to release seques-
tered intracellular Ca2π and diacylglycerol activates protein
kinase C. High concentrations of CCK also activate Gs and
thereby adenylate cyclase leading to an increase in cAMP.
Details on this research have been reviewed previously
(Yule & Williams 1994; Williams 2001).
Considerable work has also been carried out localizing
the sites of Ca2π release in the apical pole of the acinar
cell and describing patterns of intracellular Ca2π signaling
(Petersen et al. 1999). Moreover, recent work has estab-
lished the existence of alternative Ca2π mobilizing messen-
gers including cyclic ADP ribose and nicotinic acid adenine
dinucleotide phosphate (NAADP) (Williams 2001 & 2002).
The end result is that Ca2π and protein kinase C can be
shown together to mediate the secretion of digestive en-
zymes by exocytosis of zymogen granule content. As for
other membrane fusion events, evidence indicates the par-
ticipation of SNARE proteins and small G proteins, par-
ticularly Rab3D (Chen et al. 2002). An interaction with ac-
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tin present in a subluminal membrane network that gran-
ules must traverse is also involved. How Ca2π triggers
exocytosis, however, is still not clear. A number of kinases
and phosphatases are activated by Ca2π, some are substrate
specific such as myosin light chain kinase and others are
more multifunctional such as Ca2π-calmodulin activated ki-
nase II and protein kinase C. However, it is not clear
whether any of these actions trigger secretion or whether
there is a Ca2π sensor on the granule membrane that acti-
vates exocytosis after docking and priming steps which in-
volve phosphorylation events.
Non-secretory signaling pathways activated by CCK
Acinar cells are also regulated in terms of growth, gene ex-
pression, translational control of protein synthesis, cyto-
skeletal organization and energy metabolism. Although the
classical second messengers such as Ca2π, diacylglycerol,
and cAMP may regulate these functions, a number of novel
signaling pathways are also involved. Current research is
identifying these pathways in acinar cells, showing regula-
tion by CCK and illuminating the relationship of the path-
way to specific cellular functions. In most cases less is
known of how the CCKA receptor activates the pathway.
In some cases this may be through a different heterotrimeric
G protein such as G12/13. In others it involves small G pro-
teins such as Ras, Rac and Rho. It is still not clear whether
all of these novel pathways are activated directly by protein-
protein interactions or indirectly by Ca2π and other classi-
Fig. 1. Schematic dipiction of the three mitogen-activated protein kinase (MAPK) signaling cascades known to be activated by CCK
receptors. Each three-module kinase cascade is shown being activated by a small G protein. Individual MAPK’s signal to the nucleus by
phosphorylating transcription factors either directly or through other kinases. In addition, p38 has demonstrated effects on actin dynamics.
While CCK activates ERKs, JNKs and p38 in pancreatic acinar cells, specific upstream components activated by CCK in the JNK and p38
cascades remain to be identified and the multiplicity of potential regulators are taken from a variety of cell types. Activation of these cascades
coordinates the regulation of different genetic programs. Modified from Schäfer & Williams (2000).
cal second messengers. In some cases non-receptor tyrosine
kinases may also be involved.
Mitogen-activated kinase cascades.
Mitogen-activated protein kinases (MAPKs) are serine-
threonine directed kinases that were originally identified as
mitogen-activated but are now known to be activatable by
a number of hormones, neurotransmitters and different
kinds of stress. MAPKs are known to regulate a number of
cellular processes and to be involved in control of cell
growth, differentiation, survival, apoptosis and cytokine
production. All MAPK cascades are composed of three
protein kinases acting in series (Widmann et al. 1999). Thus
each MAPK is activated by a MAPK kinase (MAPKK or
MKK) which is in turn activated by a MAPK kinase kinase
(MAPKKK or MKKK). Each MAPK is activated by dual
phosphorylation of tyrosine and threonine residues in a T-
X-Y sequence and phosphospecific antibodies to these epi-
topes are now often used to assess activation of each path-
way. At the upstream end of each cascade MAPKKKs re-
ceive information through small G proteins of the Ras su-
perfamily. Currently, there are five independent MAPK
cascades. Three have been identified in pancreatic acinar
cells and all are activated by CCK and CCKA receptors.
These are the cascades leading to ERKs, JNKs and p38 and
are diagrammed in fig. 1.
CCK was first shown to rapidly increase tyrosine phos-
phorylation and kinase activity of ERK1/2, originally
known as p44 and p42 MAPK respectively based on their
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molecular mass (Duan & Williams 1994). Subsequently,
CCK was shown to increase the activity of the upstream
kinases MEK1/2 (Duan et al. 1995) three forms of Raf
(RafA RafB and cRaf1) which are the MKKK for this
pathway (Dabrowski et al. 1997). A kinase downstream of
ERK, p90 RSK also known as MAPKAPK-1 was also
shown to be activated by CCK (Bragado et al. 1997). Most
of these assays involve immunoprecipitation of specific pro-
teins followed by a kinase assay. Two MEK inhibitors,
PD98059 and U0126 block ERK and p90RSK activation
in acinar cells. Both ERKs and p90RSK phosphorylate
transcription factors such as Elk and c-myc as well as
Histone H3.
Classically, the ERK cascade is activated by Ras but the
importance of Ras in CCK activation of this MAPK cas-
cade is unclear. Both CCKA and CCKB receptors activate
ERKs in a transfected model cell (Dabrowski et al. 1997b)
and gastrin activates ERKs in the pancreas derived AR42J
cell line (Seva et al. 1997). Dabrowski et al. (1996a & 1997a)
found that CCK and EGF activate ERK1/2 by different
mechanisms. EGF stimulation induced autophosphoryla-
tion of the EGF receptor and had a strong effect to increase
tyrosine phosphorylation of the adapter protein Shc and
formation of a Shc-Grb2-SOS complex where SOS is a
known Ras guanine nucleotide exchange factor. EGF also
increased the fraction of Ras which had GTP bound and is
presumed to be the activated state which can bind Raf.
These actions were unaffected by the protein kinase C an-
tagonist GF-109203X. By contrast, CKK had no effect on
EGF receptor phosphorylation. Some other G protein
coupled receptors are known to act by ‘‘transactivating’’ the
EGF receptor but this does not seem to be the case for the
CCKA receptor in rat acinar cells (Dabrowski et al. 1996a).
CCK had a weaker effect on Shc phosphorylation, forma-
Fig. 2. Schematic depiction of the pathways leading to ERK 1/2 activation stimulated by CCK and EGF receptors. While the EGF receptor
signals by its tyrosine kinase (TK) activity through adaptor proteins to Ras, CCK has at most a minor potential pathway through Ras and
a major pathway involving PKC acting to activate Raf. The multiple forms of Raf, MEK and ERKs listed have all been shown to be
activated by CCK. Modified from Dabrowski et al. (1997).
tion of a Shc-Grb2-SOS complex and no measurable effect
on Ras GTP. However, the actions of CCK were blocked by
the protein kinase C inhibitor. Because CCK is a stronger
activator of Raf than is EGF and this action is blocked by
the protein kinase C inhibitor, it was postulated that CCK
receptor leads to activation of the ERK kinase cascade by
protein kinase C phosphorylation of Raf. These differences
are diagrammed in fig. 2. Activation of Ras by CCK is un-
clear, however, as an earlier study showed, CCK increased
the rate of GTP binding to Ras in permeabilized acini
(Duan et al. 1995). The lack of importance of active Ras in
the action of CCK to activate ERKs was also shown by
Nicke et al. (1999) who used an adenoviral vector to express
dominant negative N17 Ras in overnight cultured rat acini.
Expression of this dominant negative Ras blocked the ac-
tion of EGF to activate ERKs but had no effect on ERK
activation by CCK. It did, however, inhibit DNA synthesis
and blocked activation of JNKs. These results support the
concept of different mechanisms for CCK and EGF to acti-
vate ERKs. It is possible that the tyrosine phosphorylation
of Shc induced by CCK is involved in regulation a different
pathway. The nature of the tyrosine kinase involved remains
to be identified although it could well be a member of the
Src family or p125FAK.
JNKs, named for their activity as Jun kinases are also
known as stress induced kinase as they are activated in
many cells by proinflammatory cytokines and environmen-
tal stress (Karin 1998). JNKs phosphorylate the amino ter-
minal transactivation domain of the c-Jun transcription fac-
tor which can then dimerize with fos and control the expres-
sion of a number of genes. JNKs can be assayed using a
GST-Jun amino terminal fusion protein either to bind and
pull down active JNK followed by a kinase reaction or with
an in gel kinase assay which has the advantage of separating
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the p46 and p55 forms of JNK. Since JNK is activated
similar to ERKs by dual phosphorylation, JNK activity can
also be inferred by Western blotting with antibody to its
specific phosphoepitope. The upstream kinases have not
been studied in acinar cells but those active in other cells
are listed in fig. 1. Dabrowski et al. (1996b) first showed
that CCK could activate JNKs in pancreatic acini. Carba-
chol and bombesin had a smaller effect while VIP had no
effect. When JNK and ERK activity were compared, the
effect of CCK to activate JNKs was slower requiring 30
min. to reach maximum and also required a higher concen-
tration of CCK. In vivo the activity of pancreatic JNK is
quite low indicating that basal levels are increased by isolat-
ing acini. Caerulein infusion at physiological levels in-
creased JNK 4 times while supraphysiological levels used to
induce pancreatitis increased JNK activity 25 fold (Dabrow-
ski et al. 1996b). The increase in JNK by high concen-
trations of CCK (or caerulein) may reprecent a stress re-
sponse. At present, it is unknown whether JNK activation
is protective or deleterious in pancreatitis and which genes
are activated. A recent in vivo study showed that a JNK
inhibitor blocked the oedema but not other components of
pancreatitis (Wagner et al. 2000).
The p38 MAPKs were originally identified in yeast as a
kinase activated by high osmolarity but are known to be
activated by both stress and growth stimuli in mammalian
cells. Four different isoforms are now known and desig-
nated a, b, g and d. Their identified MAPKKs are known
as MKK3, MKK4 and MKK6. At the level of small G
Fig. 3. CCK activates the PI3K-PKB-mTOR pathway to regulate translation initiation in pancreatic acinar cells. PI3K has actions both as
a lipid kinase to phosphorylate inositol containing lipids and as a protein kinase where it phosphorylates and activates PKB which then
phosphorylates and stimulates mTOR. PKB most likely has other actions such as phosphorylating GSK-3. mTOR is responsible (at least
in part) for phosphorylating eIF4E-BP that results in release of eIF4E and the formation of the messenger RNA cap binding complex
necessary for the global increase in transition. mTOR also phosphorylates p70 S6K which is responsible for phosphorylating ribosomal
protein S6 which increases the translation of mRNAs with 5ø polypyrimide tracts.
proteins, Cdc42 is a known activator of this cascade (fig. 1).
The presence of p38 MAPK in rat acinar cells was shown
by Schäfer et al. (1998). CCK increased the activity of p38
measured using a GST-ATF2 fusion protein substrate after
immunoprecipitation. p38 was activated rapidly within 1
min. and by physiological levels of CCK. Carbachol and
bombesin but not VIP also activated p38, although the
greatest increase was induced by hyperosmolarity. This was
parallel by an increase in tyrosyl phosphorylation of the
p38 activation site. Using a specific inhibitor of p38,
SB203580, p38 was shown to be required for the activation
of the downstream kinase, MAPKAP-kinase 2 in pancreatic
acini. MAPKAPK-2 is known to phosphorylate HSP27
previously shown to be phosphorylated in response to CCK
(Groblewski et al. 1997) and SB2030580 was found to block
the phosphorylation of HSP27 induced by CCK (Schäfer et
al. 1998). By use of a rhodamine phalloidin binding assay
and confocal fluorescence microscopy it was shown that
CCK induced changes in the actin cytoskeleton were largely
blocked by SB203580. Thus, this pathway from p38 to
HSP27 appears important for regulating the actin cytoskey-
eton in acinar cells. That this effect was mediated by phos-
phorylation of HSP27 was confirmed by transiently over
expressing HSP27 in CHO cells stably expressing CCKA
receptors (Schäfer et al. 1999). The protection against CCK
alterations in the actin cytoskeleton induced by HSP27 was
lost when the phosphorylatable serine residues were mu-
tated to glycine or alanine. p38 MAPK may also mediate
some of the transcriptional regulation seen in response to
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CCK as in other cells, p38 phosphorylates transcription
factors including ATF-2, CHOP, and CREB.
PI3K-PKB-mTOR signaling.
A signaling pathway that primarily regulates protein syn-
thesis but which also is required for mitogenesis and has
anti-apoptotic and metabolic effects is the PI3K-PKB-
mTOR pathway. This pathway can be activated in acinar
cells by CCK as well as by insulin and acetylcholine acting
on m3 receptors. While the pathway includes three kinases
in series similar to the MAP kinase cascades, each of the
three has numerous downstream targets. Fig. 3 shows the
pathway in a linear manner aimed at controlling protein
synthesis but each of the three kinases has multiple down-
stream actions and their activation is more complicated
than shown. Thus, PI3K as a protein kinase phosphorylates
and activates protein kinase B also known as Akt while
as a lipid kinase it increases the membrane content of 3
phosphorylated phosphoinositides and thereby activates
other downstream proteins many of which bind to 3 phos-
phoinositides through pleckstrin homology domains (Can-
trell 2001). Protein kinase B is a protein kinase with
multiple targets including the mammalian Target of Rapa-
micin (mTOR) and glycogen synthase kinase-3(GSK-3)
(Vanhaesebroeck & Alessi 2000). Both PI3K and protein
kinase B possess multiple isoforms and little is known re-
garding which isoform is present in acinar cells or as to
how the CCK receptor activates PI3K. CCK increases the
activity of protein kinase B in isolated rat acini (Sans &
Williams, unpublished results) while gastrin activates PKB
in AR42J cells (Todisco et al. 2001).
More is known in acini of the targets of mTOR and how
mTOR activation is related to the translational control of
protein synthesis. Ribosomal protein S6 phosphorylation
was one of the first regulatory phosphorylation events
shown to be stimulated by CCK in acinar cells. The kinase
phosphorylating S6 is now known to be p70 S6K and this
kinase was shown to be phosphorylated and activated in
response to CCK in isolated pancreatic acini (Bragado et
al. 1997). Activation was blocked both by rapamycin, which
binds to an intracellular receptor FKBP-12 and acts as an
inhibitor of mTOR and by inhibitors of PI3K including
Wortmannin and LY294002. Gastrin, acting on CCKB re-
ceptors also activates p70 S6K in AR42J cells (Seva et al.
1997). P70 S6K is activated by a hierarchical phosphoryla-
tion at multiple sites but phosphorylation by mTOR is criti-
cal. Antibodies directed at specific phosphoserine epitopes
can also now be used to monitor p70 S6K activation. Phos-
phorylation of S6 is believed to facilitate translation of
mRNA species containing a 5ø polypyrimidine tract (socall-
ed TOP sequences) which are prominent in ribosomal pro-
teins and translation factors. Thus, the acute translational
upregulation of components of the translational machinery
may increase the overall capacity of the cell for protein syn-
thesis (Proud & Denton 1997).
The other target of mTOR playing a role in translational
control in acinar cells in response to CCK is the binding
protein for eukaryotic initiation factor 4E (eIF4E-BP), also
known as PHAS-I because it was identified as a heat and
acid stable phosphoprotein regulated by insulin (Proud &
Denton 1997). This protein and a highly related second iso-
form are small proteins of 10–12 kDa which are rapidly
phosphorylated on both Ser and Thr residues in response to
numerous external stimuli including hormones, cytokines,
growth factors, amino acids and mitogens (Hershey & Mer-
rick 2000). At least 5 sites have been identified phosphoryl-
ated by multiple kinases but with mTOR the most import-
ant regulator. Phosphorylation of eIF4E-BP releases eIF4E,
the mRNA cap binding protein which is probably the most
rate limiting of the initiation factors. eIF4E then binds to a
scaffolding protein eIF4G and eIF4A, a RNA helicase, to
form a complex known as eIF4F which binds to the mRNA
cap, commits this particular mRNA molecule to translation
and leads to the binding of the 40S ribosomal preinitiation
complex. CCK acts on isolated acini and in vivo to stimulate
eIF4E-BP phosphorylation, the release of eIF4E and the
formation of a eIF4E-eIF4G complex (Bragado et al.
1998 & 2000). These actions are blocked by rapamycin and
PI3K inhibitors all of which also blocked global protein
synthesis in rat pancreatic acini, reducing basal synthesis
and blocking the increase in response to CCK (Bragado et
al. 1998). In AR42J cells, rapamycin similarly inhibits
eIF4E-BP phosphorylation in response to gastrin (Pyronnet
et al. 1998). Thus, both CCK receptors can activate this
pathway.
In a separate signaling pathway CCK stimulation of aci-
nar cells increases the phosphorylation of eIF4E itself (Bra-
gado et al. 2000). This phosphorylation is known to en-
hance the affinity of eIF4E for the mRNA cap but the im-
portance of this in regulating acinar cell protein synthesis is
unclear. In other cells this phosphosylation has been shown
to be mediated by mnk kinases which are activated by
ERKs and p38 MAPK (fig. 1).
Other signaling pathways.
CCK stimulation of rat pancreatic acini and gastrin stimu-
lation of AR42J cells is known to enhance the tyrosine
phosphorylation of a variety of proteins (Williams 2001).
The identity of some of these substrates as well as the speci-
fic tyrosine kinases involved are beginning to emerge. Sev-
eral tyrosyl-phosphorylated proteins are adaptor proteins
such as Shc and IRS-1 and others are present as part of the
focal adhesion complex (p125FAK and paxillin). Tyrosine ki-
nases which have been reported to be activated by CCK
include Src, p125FAK and Pyk2. A potential role for some
of these proteins is in regulation of the actin cytoskeleton.
This almost certainly also involves the small G protein Rho.
Another signaling pathway recently shown to be acti-
vated by CCK in pancreatic acini is NF-kB, a transcription
factor important in the inflammatory response but with po-
tential other roles. NF-kB is sequestered in an inactive form
in resting cells through an association with the inhibitory
protein, Ikb. Cell stimulation leads to phosphorylation and
degradation of IKb followed by translocation of NF-kb, to
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the nucleus where it regulates target genes. CCK was shown
to activate NF-kb through mechanisms involving increased
cytoplasmic free calcium and activation of protein kinase C
(Tando et al. 1999; Han & Logsdon 2000). While activation
of this pathway clearly occurs in caerulein-induced experi-
mental pancreatitis, whether it has a physiological role in
CCK action remains to be determined.
Conclusion
The last decade has shown that CCK receptors activate a
multiplicity of intracellular signal transduction mechanisms
in acinar cells that regulate not only secretion but also pro-
tein synthesis, growth and metabolism. These pathways are
present in most differentiated cell types and the pathways
activated by CCK in rodent acinar cells most likely occur
in other target cells bearing CCK receptors. However, the
cellular context often also affects the pathways activated
and different cell types may contain different isoforms of
signaling intermediates. Thus, although the acinar cell is an
excellent model cell other cell types also need to be studied.
In many cases the machanism by which the CCK receptor
couples to a specific intracellular pathway is not fully under-
stood. In some cases distinct heterotrimeric G proteins may
be involved or the pathway is regulated by a classical second
messenger such as Ca2π, cAMP or diacylglycerol (protein
kinase C). Crosstalk and interaction between signaling
pathways is also an area for further investigation.
References
Bragado, M. J., A. Dabrowski, G. E. Groblewski & J. A. Williams:
CCK activates p90rsk in rat pancreatic acini through protein ki-
nase C. Amer. J. Physiol. 1997, 272, G401–G407.
Bragado, M. J., G. E. Groblewski & J. A. Williams: p70s6k is acti-
vated by CCK in rat pancreatic acini. Amer. J. Physiol. 1997,
273, C101–C109.
Bragado, M. J., G. E. Groblewski & J. A. Williams: Regulation of
protein synthesis by cholecystokinin in rat pancreatic acini in-
volves PHAS-1 and the p70 S6 kinase pathway. Gastroenterology
1998, 115, 733–742.
Bragado, M. J., M. Tashiro & J. A. Williams: Regulation of the
initiation of pancreatic digestive enzyme protein synthesis by cho-
lecystokinin in rat pancreas in vivo. Gastroenterology 2000, 119,
1731–1739.
Cantrell, D. A.: Phosphoinositide 3-kinase signaling pathways. J.
Cell Sci. 2001, 114, 1439–1445.
Chen, X., J. A. S. Edwards, C. D. Logsdon, S. A. Ernst & J. A.
Williams: Dominant negative Rab3D inhibits amylase release
from mouse pancreatic acini. J. Biol. Chem. 2002, 277, 18002–
18009.
Dabrowski, A., G. E. Groblewski, C. Schäfer, K.-L. Guan & J. A.
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